Furthermore, when cocultured with two CD21-low (474 and 889 CD21 ABC, respectively) patient-derived xenograft (PDX) models of T-ALL (PDX1 and PDX2), NM2 Fab-CAR-T specifically eliminated both T-ALL lymphoblast populations (Fig. 5G). The gene discussed is CR2; the disease is acute lymphoblastic leukemia.